Challenges Integrating Technology into Specialty Pharmacy

Video

Gregory R. Morris, chief commercial officer at VirMedica, discusses hurdles with the use of eAccess technology in specialty pharmacy.

Gregory R. Morris, chief commercial officer at VirMedica, discusses hurdles with the use of eAccess technology in specialty pharmacy.

Recent Videos
Naloxone concept represented by wooden letter tiles.
Hand holding a Narcan Evzio Naloxone nasal spray opioid drug overdose prevention medication
Image credit: Gorodenkoff | stock.adobe.com
Pharmacist and Patient in Pharmacy | Image Credit: Gorodenkoff - stock.adobe.com
Sun Screen, Photosensitivity, Pharmacy | Image Credit: sosiukin - stock.adobe.com
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
Image Credit: © Anastasiia - stock.adobe.com
Related Content
Biosimilar, Humira | Image Credit: lexiconimages - stock.adobe.com

Patient Affordability Program for Adalimumab Biosimilar Is Launched at GoodRx

Ashley Gallagher, Associate Editor
July 25th 2024
Article
Public Health Matters: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care

Public Health Matters: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care

July 25th 2024
Podcast
FDA Approval | Image Credit: outchill - stock.adobe.com

FDA Approves Cerliponase Alfa for Expanded Indication of CLN2 Disease

Ashley Gallagher, Associate Editor
July 24th 2024
Article
Pharmacy Focus: What to Know About Medication and Summer Travel

Pharmacy Focus: What to Know About Medication and Summer Travel

July 12th 2024
Podcast
Coagulation Factor VIII, FVIII, an essential blood-clotting protein, also known as anti-hemophilic factor, AHF, 3D illustration

Intravenous Immunoglobulin Temporarily Improves Bleeding in Patients With Acquired Von Willebrand Syndrome

Luke Halpern, Assistant Editor
July 24th 2024
Article
Antibodies that cause autoimmune diseases -- Image credit: Love Employee | stock.adobe.com

Study Results Indicate Potential Method of Reversing Lupus, Opening Doors to Treatment

Gillian McGovern, Assistant Editor
July 22nd 2024
Article